{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:18:15Z","timestamp":1787167095624,"version":"build-2736575974"},"reference-count":39,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Eltrombopag (ELT) is a thrombopoietic agent approved for immune thrombocytopenia and also a potent iron chelator. Here we found that ELT exhibited dose-dependent opposing effects on in\u00a0vitro megakaryopoiesis: low concentrations (\u22646 \u00b5M, ELT6) stimulated megakaryopoiesis, but high concentrations (30 \u00b5M, ELT30) suppressed megakaryocyte (MK) differentiation and proliferation. The suppressive effects of ELT30 were reproduced by other iron chelators, supporting iron chelation as a likely mechanism. During MK differentiation, committed MK progenitors (CD34+\/CD41+ and CD34\u2212\/CD41+ cells) were significantly more sensitive than undifferentiated progenitors (CD34+\/CD41\u2212 cells) to the suppressive effects of ELT30, which resulted from both decreased proliferation and increased apoptosis. The antiproliferative effects of ELT30 were reversed by increased iron in the culture, as were the proapoptotic effects when exposure to ELT30 was short. Because committed MK progenitors exhibited the highest proliferative rate and the highest sensitivity to iron chelation, we tested whether their iron status influenced their response to ELT during rapid cell expansion. In these studies, iron deficiency reduced the proliferation of CD41+ cells in response to all ELT concentrations. Severe iron deficiency also reduced the number of MKs generated in response to high thrombopoietin concentrations by \u223c50%, compared with iron-replete cultures. Our findings support the hypothesis that although iron deficiency can stimulate certain cells and steps in megakaryopoiesis, it can also limit the proliferation of committed MK progenitors, with severity of iron deficiency and degree of thrombopoietic stimulation influencing the ultimate output. Further studies are needed to clarify how megakaryopoiesis, iron deficiency, and ELT stimulation are clinically interrelated.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004207","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T13:57:07Z","timestamp":1634738227000},"page":"13-27","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in\u00a0vitro"],"prefix":"10.1182","volume":"6","author":[{"given":"Zhi-Jian","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, MA;"},{"name":"Division of Newborn Medicine, Boston Children\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emoke","family":"Deschmann","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Women\u2019s and Children\u2019s Health, Karolinska Institutet, Stockholm, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley E.","family":"Ramsey","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1748-0894","authenticated-orcid":false,"given":"Henry A.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, MA;"},{"name":"Division of Newborn Medicine, Boston Children\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8198-9663","authenticated-orcid":false,"given":"Bethan","family":"Psaila","sequence":"additional","affiliation":[{"name":"Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichola","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Immunology and Inflammation, Imperial College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4330-6862","authenticated-orcid":false,"given":"Evangelia","family":"Vlachodimitropoulou","sequence":"additional","affiliation":[{"name":"Department of Hematology, University College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Porter","sequence":"additional","affiliation":[{"name":"Department of Hematology, University College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bussel","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Pediatrics, Weill Cornell Medicine, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Georgieff","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Neurobehavioral Development, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Sola-Visner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School, Boston, MA;"},{"name":"Division of Newborn Medicine, Boston Children\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,12,30]]},"reference":[{"issue":"16","key":"2021123016210380100_B1","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa054626","article-title":"AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP","volume":"355","author":"Bussel","year":"2006","journal-title":"N Engl J Med."},{"issue":"10004","key":"2021123016210380100_B2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(15)61107-2","article-title":"Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial","volume":"386","author":"Grainger","year":"2015","journal-title":"Lancet."},{"issue":"2","key":"2021123016210380100_B3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.scr.2012.05.001","article-title":"Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem\/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis","volume":"9","author":"Sun","year":"2012","journal-title":"Stem Cell Res (Amst)."},{"issue":"2","key":"2021123016210380100_B4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood-2011-12-399667","article-title":"Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation","volume":"120","author":"Roth","year":"2012","journal-title":"Blood."},{"issue":"17","key":"2021123016210380100_B5","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2016-10-740241","article-title":"Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator","volume":"130","author":"Vlachodimitropoulou","year":"2017","journal-title":"Blood."},{"issue":"12","key":"2021123016210380100_B6","doi-asserted-by":"crossref","first-page":"e0208102","DOI":"10.1371\/journal.pone.0208102","article-title":"Iron chelating properties of eltrombopag: investigating its role in thalassemia-induced osteoporosis","volume":"13","author":"Punzo","year":"2018","journal-title":"PLoS One."},{"issue":"3","key":"2021123016210380100_B7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/jth.13602","article-title":"Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain barrier and impairs iron-dependent hippocampal neuron dendrite development","volume":"15","author":"Bastian","year":"2017","journal-title":"J Thromb Haemost."},{"key":"2021123016210380100_B8","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2018-99-110642","article-title":"Intravenous iron for the treatment of steroid-refractory idiopathic thrombocytopenic purpura","volume":"132","author":"Mouabbi","year":"2018","journal-title":"Blood."},{"issue":"10","key":"2021123016210380100_B9","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00277-019-03757-0","article-title":"Iron deficiency, an unusual cause of thrombocytopenia: results from a multicenter retrospective case-controlled study","volume":"98","author":"Huscenot","year":"2019","journal-title":"Ann Hematol."},{"issue":"10","key":"2021123016210380100_B10","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/blood-2006-04-018036","article-title":"Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes","volume":"108","author":"Pastos","year":"2006","journal-title":"Blood."},{"issue":"3","key":"2021123016210380100_B11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.seminhematol.2010.04.002","article-title":"Neonatal thrombocytopenia and megakaryocytopoiesis","volume":"47","author":"Ferrer-Marin","year":"2010","journal-title":"Semin Hematol."},{"issue":"15","key":"2021123016210380100_B12","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2010-07-293092","article-title":"Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes","volume":"117","author":"Liu","year":"2011","journal-title":"Blood."},{"issue":"458","key":"2021123016210380100_B13","doi-asserted-by":"crossref","first-page":"eaas9563","DOI":"10.1126\/scitranslmed.aas9563","article-title":"Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopag","volume":"10","author":"Kao","year":"2018","journal-title":"Sci Transl Med."},{"issue":"1","key":"2021123016210380100_B14","doi-asserted-by":"crossref","first-page":"41510","DOI":"10.1038\/srep41510","article-title":"Deferasirox-induced iron depletion promotes BclxL downregulation and death of proximal tubular cells","volume":"7","author":"Martin-Sanchez","year":"2017","journal-title":"Sci Rep."},{"issue":"24","key":"2021123016210380100_B15","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1182\/blood-2011-12-398834","article-title":"Mcl-1 and Bcl-x(L) coordinately regulate megakaryocyte survival","volume":"119","author":"Debrincat","year":"2012","journal-title":"Blood."},{"issue":"6","key":"2021123016210380100_B16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1182\/blood-2017-11-742684","article-title":"Apoptosis in megakaryocytes and platelets: the life and death of a lineage","volume":"131","author":"McArthur","year":"2018","journal-title":"Blood."},{"issue":"3","key":"2021123016210380100_B17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0091270010368677","article-title":"Clinical pharmacokinetics, platelet response, and safety of eltrombopag at supratherapeutic doses of up to 200 mg once daily in healthy volunteers","volume":"51","author":"Matthys","year":"2011","journal-title":"J Clin Pharmacol."},{"issue":"12","key":"2021123016210380100_B18","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3324\/haematol.2016.146746","article-title":"Revealing eltrombopag\u2019s promotion of human megakaryopoiesis through AKT\/ERK-dependent pathway activation","volume":"101","author":"Di Buduo","year":"2016","journal-title":"Haematologica."},{"issue":"1","key":"2021123016210380100_B19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/cells9010031","article-title":"The thrombopoietin receptor agonist eltrombopag inhibits human cytomegalovirus replication via iron chelation","volume":"9","author":"Vogel","year":"2019","journal-title":"Cells."},{"issue":"12","key":"2021123016210380100_B20","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood-2013-10-534743","article-title":"Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug","volume":"123","author":"Desmond","year":"2014","journal-title":"Blood."},{"issue":"9","key":"2021123016210380100_B21","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1124\/dmd.111.040170","article-title":"Metabolism and disposition of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist, in healthy human subjects","volume":"39","author":"Deng","year":"2011","journal-title":"Drug Metab Dispos."},{"issue":"21","key":"2021123016210380100_B22","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood-2018-01-826784","article-title":"Eltrombopag mobilizes iron in patients with aplastic anemia [published correction appears in Blood. 2018;132(4):459]","volume":"131","author":"Zhao","year":"2018","journal-title":"Blood."},{"issue":"18","key":"2021123016210380100_B23","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1182\/blood.2019002039","article-title":"Low iron promotes megakaryocytic commitment of megakaryocytic-erythroid progenitors in humans and mice","volume":"134","author":"Xavier-Ferrucio","year":"2019","journal-title":"Blood."},{"issue":"6","key":"2021123016210380100_B24","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/jth.12884","article-title":"Increased expression of HIF2\u03b1 during iron deficiency-associated megakaryocytic differentiation","volume":"13","author":"Jimenez","year":"2015","journal-title":"J Thromb Haemost."},{"issue":"5","key":"2021123016210380100_B25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ajh.23682","article-title":"Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin","volume":"89","author":"Evstatiev","year":"2014","journal-title":"Am J Hematol."},{"issue":"6","key":"2021123016210380100_B26","doi-asserted-by":"crossref","first-page":"E88","DOI":"10.1002\/ajh.24705","article-title":"Therapy induced iron deficiency in children treated with eltrombopag for immune thrombocytopenia","volume":"92","author":"Lambert","year":"2017","journal-title":"Am J Hematol."},{"issue":"5","key":"2021123016210380100_B27","first-page":"240","article-title":"Real-world experience of eltrombopag in immune thrombocytopenia","volume":"10","author":"Mishra","year":"2020","journal-title":"Am J Blood Res."},{"issue":"52","key":"2021123016210380100_B28","doi-asserted-by":"crossref","first-page":"48814","DOI":"10.1074\/jbc.M109551200","article-title":"Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase","volume":"276","author":"Kayyali","year":"2001","journal-title":"J Biol Chem."},{"issue":"5","key":"2021123016210380100_B29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00043426-200206000-00011","article-title":"Thrombocytopenia in children with severe iron deficiency","volume":"24","author":"Perlman","year":"2002","journal-title":"J Pediatr Hematol Oncol."},{"issue":"10","key":"2021123016210380100_B30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/000992286600501008","article-title":"Thrombocytopenia associated with iron deficiency anemia. A report of five cases","volume":"5","author":"Lopas","year":"1966","journal-title":"Clin Pediatr (Phila)."},{"issue":"1","key":"2021123016210380100_B31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-80-1-111","article-title":"Letter: Thrombocytopenia and iron deficiency","volume":"80","author":"Sonneborn","year":"1974","journal-title":"Ann Intern Med."},{"issue":"1","key":"2021123016210380100_B32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7326\/0003-4819-81-1-132","article-title":"Letter: Thrombocytopenia and iron deficiency","volume":"81","author":"Sahud","year":"1974","journal-title":"Ann Intern Med."},{"key":"2021123016210380100_B33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1542\/peds.34.3.315","article-title":"The platelets in iron-deficiency anemia. I. The response to oral and parenteral iron","volume":"34","author":"Gross","year":"1964","journal-title":"Pediatrics."},{"issue":"4","key":"2021123016210380100_B34","first-page":"433","article-title":"[Usefulness of immature platelet fraction measurement for diagnosis and monitoring of iron deficiency associated thrombocytopenia: about two cases]","volume":"78","author":"Blandini\u00e8res","year":"2020","journal-title":"Ann Biol Clin (Paris)."},{"issue":"1","key":"2021123016210380100_B35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ng.3465","article-title":"A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency","volume":"48","author":"Jabara","year":"2016","journal-title":"Nat Genet."},{"issue":"1","key":"2021123016210380100_B36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood.V43.1.111.111","article-title":"Megakaryocytopoiesis in experimental iron deficiency anemia","volume":"43","author":"Choi","year":"1974","journal-title":"Blood."},{"issue":"4","key":"2021123016210380100_B37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/09537104.2017.1316481","article-title":"Developmental differences between newborn and adult mice in response to romiplostim","volume":"29","author":"Sparger","year":"2018","journal-title":"Platelets."},{"issue":"4","key":"2021123016210380100_B38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1203\/pdr.0b013e3180332c18","article-title":"Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates","volume":"61","author":"Sola-Visner","year":"2007","journal-title":"Pediatr Res."},{"issue":"1","key":"2021123016210380100_B39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000280413","article-title":"Differences between newborn and adult mice in their response to immune thrombocytopenia","volume":"98","author":"Hu","year":"2010","journal-title":"Neonatology."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/1\/13\/1856171\/advancesadv2021004207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/1\/13\/1856171\/advancesadv2021004207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T11:24:31Z","timestamp":1640863471000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/1\/13\/477337\/Iron-status-influences-the-response-of-cord-blood"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,30]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004207","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,30]]}}}